Cargando…
Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single pat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319862/ https://www.ncbi.nlm.nih.gov/pubmed/35886058 http://dx.doi.org/10.3390/genes13071275 |
_version_ | 1784755653732990976 |
---|---|
author | Rosina, Erica Pezzani, Lidia Pezzoli, Laura Marchetti, Daniela Bellini, Matteo Pilotta, Alba Calabrese, Olga Nicastro, Emanuele Cirillo, Francesco Cereda, Anna Scatigno, Agnese Milani, Donatella Iascone, Maria |
author_facet | Rosina, Erica Pezzani, Lidia Pezzoli, Laura Marchetti, Daniela Bellini, Matteo Pilotta, Alba Calabrese, Olga Nicastro, Emanuele Cirillo, Francesco Cereda, Anna Scatigno, Agnese Milani, Donatella Iascone, Maria |
author_sort | Rosina, Erica |
collection | PubMed |
description | In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single patient have been estimated to occur in approximately 2–7.5% of diagnosed cases, with higher frequency in consanguineous families. Here, we report the clinical and molecular characterisation of eight illustrative patients for whom trio-WES allowed for identifing more than one genetic condition. Double homozygosity represented the causal mechanism in only half of them, whereas the other half showed peculiar multilocus combinations. The paper takes into consideration difficulties and learned lessons from our experience and therefore supports the powerful role of wide analyses for ascertaining multiple genetic diseases in complex patients, especially when a clinical suspicion could account for the majority of clinical signs. It finally makes clear how a patient’s “deep phenotyping” might not be sufficient to suggest the presence of multiple genetic diagnoses but remains essential to validate an unexpected multilocus result from genetic tests. |
format | Online Article Text |
id | pubmed-9319862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93198622022-07-27 Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients Rosina, Erica Pezzani, Lidia Pezzoli, Laura Marchetti, Daniela Bellini, Matteo Pilotta, Alba Calabrese, Olga Nicastro, Emanuele Cirillo, Francesco Cereda, Anna Scatigno, Agnese Milani, Donatella Iascone, Maria Genes (Basel) Article In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single patient have been estimated to occur in approximately 2–7.5% of diagnosed cases, with higher frequency in consanguineous families. Here, we report the clinical and molecular characterisation of eight illustrative patients for whom trio-WES allowed for identifing more than one genetic condition. Double homozygosity represented the causal mechanism in only half of them, whereas the other half showed peculiar multilocus combinations. The paper takes into consideration difficulties and learned lessons from our experience and therefore supports the powerful role of wide analyses for ascertaining multiple genetic diseases in complex patients, especially when a clinical suspicion could account for the majority of clinical signs. It finally makes clear how a patient’s “deep phenotyping” might not be sufficient to suggest the presence of multiple genetic diagnoses but remains essential to validate an unexpected multilocus result from genetic tests. MDPI 2022-07-19 /pmc/articles/PMC9319862/ /pubmed/35886058 http://dx.doi.org/10.3390/genes13071275 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rosina, Erica Pezzani, Lidia Pezzoli, Laura Marchetti, Daniela Bellini, Matteo Pilotta, Alba Calabrese, Olga Nicastro, Emanuele Cirillo, Francesco Cereda, Anna Scatigno, Agnese Milani, Donatella Iascone, Maria Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title | Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title_full | Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title_fullStr | Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title_full_unstemmed | Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title_short | Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients |
title_sort | atypical, composite, or blended phenotypes: how different molecular mechanisms could associate in double-diagnosed patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319862/ https://www.ncbi.nlm.nih.gov/pubmed/35886058 http://dx.doi.org/10.3390/genes13071275 |
work_keys_str_mv | AT rosinaerica atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT pezzanilidia atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT pezzolilaura atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT marchettidaniela atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT bellinimatteo atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT pilottaalba atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT calabreseolga atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT nicastroemanuele atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT cirillofrancesco atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT ceredaanna atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT scatignoagnese atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT milanidonatella atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients AT iasconemaria atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients |